Skip to main content

Closed

AGEN: Agenus Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth-33.8% / yr

Operating margin6.6%

ROIC10.5%

Financially safe

Stretched

Debt / equity-1.38×

Interest coverage0.1×

Current ratio0.38×

Valuation

Unrated

P/E ratio3.5×

Agenus Inc.

AGENNASDAQ Capital Market·USD·Closed

Agenus Inc.

AGENNASDAQ·USD·Closed

$7.50

−5.18%

$7.50

−$0.41 (5.18%)

52W Range

80thpctl

Volume

0.39×avg

Mkt Cap

312.32MUSD

P/E

3.5TTM

Div Yield

–ann

52W Range

80thpctl

Volume

0.39×avg

Market Cap

312.32MUSD

P/E Ratio

3.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings